Work

Selective Inhibition of ALK2 Signaling Suppresses Serum Hepcidin and Increases Serum Iron

Year: 2020

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2020-139486

Authors: Thomas A Backus, Natalia Medeiros, Evan Lema, Ffolliott Fisher, Jasbir Seehra, Jennifer Lachey

Institution: Keros Therapeutics (United States)

Language: English

Topic: Iron Metabolism and Disorders

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3097309782

Cites:

Cited by:

Related to: 10